Subscribe to Newsletter

Manufacture

Manufacture Contract Development Services

Twenty-First Century Cell Therapy

| Denis Bedoret

When making advanced medicines, the cost of manufacture must be lower than reimbursement

Manufacture Small Molecules

Bright Spark

| James Strachan

Could electrochemistry give drug discovery and manufacturing a boost?

Manufacture Standards & Regulation

Making Therapeutic History

| William Aryitey

The FDA approval of Kymriah marks the first CAR-T cell-based gene therapy available in the US

Manufacture Drug Delivery

The Golden Touch

| James Strachan

What does “manufacturing” drugs in the body mean for chemotherapy?

Manufacture Analytical Science

Out with the Old, in with the New?

| Alex Perieteanu

New analytical techniques could be used alongside old ones to get the best of both worlds

Manufacture Business Practice

Here’s to Shared Successes!

| Stephanie Vine

This issue marks The Medicine Maker's third birthday!

Manufacture Bioprocessing - Upstream & Downstream

Banking on Cell Therapy

| Steve Oh

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

Manufacture Bioprocessing - Upstream & Downstream

The Big (Bio) Freeze

| John Morris

When it comes to cryopreserving cell therapies, there's a right way - and a wrong way…

Manufacture Advanced Medicine

What About Gene Therapies?

| Linda Randall

As fast as gene therapies are progessing, there's still one major hurdle to overcome: cost

Manufacture Business Practice

Conducting the Supply Chain Orchestra

| Simon Ellison

To effectively develop advanced therapies, you need the right supply chain management

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register